Christopher Swain

Current Organisation: Cambridge MedChem Consulting
(some projects in the list below may not be associated with this organisation)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£4,007,260

May 10 - Mar 14

Developmental Clinical Studies: Inhibition of C-reactive protein for treatment of cardiovascular & inflammatory diseases

MRC award to University College London and Mark Pepys

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}